Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Boostrix and Menactra Co-administration in Adolescents
NCT00282295Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2006
- Primary completion
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) in Tetanus, diphtheria, pertussis, sponsored by GSK. Started Jan 2006; status: completed.
02
Drugs
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT00282295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282295.